International Journal of Drug Policy
Volume 13, Issue 3 , Pages 145-148 , September 2002

Better models for AIDS prevention: HIV control is vector control

References 

  1. Alcabes, P., Grund, J.-P., Beniowski, M., Bozek, E., Kaciuba, A., & Zielinski, A. (1998). Possible epidemic spread of HIV by syringe-based drug sharing in Poland: paradigm for the new AIDS frontier. In 12th World AIDS Conference, Geneva.
  2. Alcabes P, Beniowski M, Grund J-PC. Needle and syringe exchange in Poland the former Soviet Union: A new approach to community-impact studies. Journal of Drug Issues. 1999;29:861–880
  3. Bastos FI, Strathdee SA. Evaluating effectiveness of syringe exchange programmes: current issues and future prospects. Social Science in Medicine. 2000;51:1771–1782
  4. Bruneau J, Lamothe F, Franco E, Lachance N, Desy M, Soto J, et al. High rates of HIV infection among injection drug users participating in needle exchange programs in Montreal: Results of a cohort study. American Journal of Epidemiology. 1997;146:994–1002
  5. CDC (Centers for Disease Control and Prevention) (1982). Update on Kaposi's sarcoma and opportunistic infections in previously healthy persons—United States. Morbidity and Mortality Weekly Report, 31, 294 and 300–301.
  6. Chin, J. (Ed.). (2000). Control of communicable diseases manual (pp. 310–323). 17th ed. Washington, DC: American Public Health Association.
  7. Choopanya K, Vanichseni S, Des Jarlais DC, Plangsringarm K, Sonchai W, Carballo M, et al. Risk factors and HIV seropositivity among injecting drug users in Bangkok. AIDS. 1991;5:1509–1513
  8. Dehne KL, Grund J-PC, Khodakevich L, Kobyshcha Y. The HIV/AIDS epidemic among drug injectors in Eastern Europe: patterns, trends and determinants. Journal of Drug Issues. 1999;29:729–776
  9. Des Jarlais DC, Friedman SR, Novick DM, Sotheran JL, Thomas P, Yancovitz SR, et al. HIV-1 infection among intravenous drug users in Manhattan, New York City, from 1977 through 1987. Journal of the American Medical Association. 1989;261:1008–1012
  10. Des Jarlais DC, Marmor M, Paone D, Titus S, Shi Q, Perlis T, et al. HIV incidence among injecting drug users in New York City syringe-exchange programmes. Lancet. 1996;348:988–991
  11. Drucker E. Epidemic in the war zone: AIDS and community survival in New York City. International Journal of Health Services. 1990;20:601–615
  12. Drucker E, Alcabes PG, Marx P. The injection century: Massive unsterile injections and the emergence of human pathogens. Lancet. 2001;358:1989–1992
  13. Drucker E, Lurie P, Wodak A, Alcabes P. Measuring harm reduction: The effects of needle and syringe exchange programs and methadone maintenance on the ecology of HIV. AIDS. 1998;12(suppl A):S217–S230
  14. Drucker E, Vermund SH. Estimating population prevalence of human immunodeficiency virus infection in urban areas with high rates of intravenous drug use: A model of the Bronx in 1988. American Journal of Epidemiology. 1989;130:133–142
  15. Hagan H, Jarlais DC, Friedman SR, Purchase D, Alter MJ. Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program. American Journal of Public Health. 1995;85:1531–1537
  16. Hethcote, H. W., & Yorke, J. A. (1984). Gonorrhea transmission dynamics and control. Lecture notes in biomathematics 56. Heidelberg: Springer Verlag.
  17. Holtgrave DR, Pinkerton SD, Jones TS, Lurie P, Vlahov D. Cost and cost-effectiveness of increasing access to sterile syringes and needles as an HIV prevention intervention in the United States. Journal of Acquired Immune Deficiency Syndrome and Human Retrovirology. 1998;18(Suppl 1):S133–S138
  18. Hudgens MG, Longini IM, Vanichseni S, Hu DH, Kitayaporn D, Mock PA, et al. Subtype-specific transmission probabilities for Human Immunodeficiency Virus among injecting drug users in Bangkok, Thailand. American Journal of Epidemiology. 2002;155:159–168
  19. Hurley SF, Jolley DJ, Kaldor JM. Effectiveness of needle-exchange programmes for prevention of HIV. Lancet. 1997;349:1797–1800
  20. Johnson AM, Mercer CH, Erens B, Copas AJ, McManus S, Wellings K, et al. Sexual behaviour in Britain: partnerships, practices, and HIV risk behaviours. Lancet. 2001;358:1835–1842
  21. Kaplan EH. A method for evaluating needle exchange programs. Statistics in Medicine. 1994;13:2179–2187
  22. Kaplan EH. Operational modeling of needle exchange programs. In:  Moses L,  Vlahov D editor. Workshop on Needle Exchange and Bleach Distribution Programs. Washington DC: National Academy Press; 1994;
  23. Kaplan EH, Heimer R. A circulation theory of needle exchange [editorial]. AIDS. 1994;8:567–574
  24. Kaplan EH, Khoshnood K, Heimer R. A decline in HIV-infected needles returned to New Haven's needle exchange program: client shift or needle exchange?. American Journal of Public Health. 1994;84:1991–1994
  25. Kaplan EH, O'Keefe E. Let the needles do the talking! Evaluating the New Haven needle exchange. Interfaces. 1993;23:7–26
  26. Keene J, Stimson GV, Jones S, Parry-Langdon N. Evaluation of syringe-exchange for HIV prevention among injecting drug users in rural and urban areas of Wales. Addiction. 1993;88:1063–1070
  27. Lurie P. Invited commentary: le mystere de Montreal. American Journal of Epidemiology. 1997;146:1003–1006
  28. Lurie P, Reingold AL, Bowser B, Chen D, Joley J, Guydish J, et al. The public health impact of needle exchange programs in the United States and abroad. San Francisco, CA: University of California Press; 1993;
  29. Moss AR. Epidemiology and the politics of needle exchange. American Journal of Public Health. 2000;90:1385–1387 this quote on p. 1386
  30. Royce RA, Sena A, Cates W, Cohen MS. Sexual transmission of HIV. New England Journal of Medicine. 1997;336:1072–1078
  31. Schechter MT, Strathdee SA, Cornelisse PG, Currie S, Patrick DM, Rekart ML, et al. Do needle exchange programmes increase the spread of HIV among injection drug users?: an investigation of the Vancouver outbreak. AIDS. 1999;13:F45–F51
  32. Schoenbaum EE, Hartel D, Selwyn PA, Klein RS, Davenny K, Rogers M, et al. Risk factors for human immunodeficiency virus infection in intravenous drug users. New England Journal of Medicine. 1989;321:874–879
  33. Singer M, Baer HA, Scott G, Horowitz S, Weinstein B. Pharmacy access to syringes among injecting drug users: follow-up findings from Hartford, Connecticut. Public Health Reports. 1998;113(Suppl 1):81–89
  34. Small CB, Klein RS, Friedland GH, Moll B, Emeson EE, Spigland I. Community-acquired opportunistic infections and defective cellular immunity in heterosexual drug abusers and homosexual men. American Journal of Medicine. 1983;74:433–441
  35. Stimson G, Alldritt L, Dolan K, Donoghoe M. Preventing the spread of HIV in injecting drug users—the experience of syringe-exchange schemes in England and Scotland. NIDA Research Monograph. 1988;90:302–310
  36. Strathdee SA, Patrick DM, Currie SL, Cornelisse PG, Rekart ML, Montaner JS, et al. Needle exchange is not enough: lessons from the Vancouver injecting drug use study. AIDS. 1997;11:F59–F65
  37. United Nations General Assembly. (2001). Global crisis—global action. Declaration of commitment on HIV/AIDS. 27 June.
  38. United Nations Programme on AIDS. AIDS Epidemic Update 2001.
  39. Valleroy LA, Weinstein B, Jones TS, Groseclose SL, Rolfs RT, Kassler WJ. Impact of increased legal access to needles and syringes on community pharmacies' needle and syringe sales—Connecticut, 1992–1993. Journal of Acquired Immune Deficiency Syndrome and Human Retrovirology. 1995;10:73–81
  40. Vickerman P, Watts C. The impact of an HIV prevention intervention for injecting drug users in Svetlogorsk, Belarus: model predictions. International Journal of Drug Policy. 2002;13:3

PII: S0955-3959(02)00077-4

doi: 10.1016/S0955-3959(02)00077-4

International Journal of Drug Policy
Volume 13, Issue 3 , Pages 145-148 , September 2002

Article Tools